Derleme

Biosensor Platforms for Cancer Derived Exosomes Detection

Cilt: 2 Sayı: 3 30 Temmuz 2021
Kübra Kelleci *, Sevil Özer
PDF İndir
TR EN

Biosensor Platforms for Cancer Derived Exosomes Detection

Öz

Early diagnosis is one of the biggest challenges in the fight against cancer. Traditional cancer diagnosis methods have some disadvantages such as requiring expertise, involving invasive procedures, radiation exposure, high cost and loss of time. For this reason, current research has focused on the development of faster, reliable and cost-effective diagnostic methods. The use of biomarkers present in body fluids has been promising in this regard. Exosomes secreted by cells into body fluids and responsible for intercellular communication are biological nanoparticles produced by natural pathways. Studies have shown that the change in microenvironmental conditions during tumor development changes exosome secretion. Due to their high cellular activities, tumor cells produce a much higher rate of exosome than healthy cells. Therefore, it is known that the number of exosomes in body fluids is significantly enriched compared to other cells and can act as a diagnostic biomarker alone. Cancer-derived exosomes are very interesting for early detection of cancer and evaluation of therapeutic response. Biosensor is an analytical device used to detect an analyte that combines a biological component with a physicochemical detector. Nowadaysthere is an increasing interest in developing cancer biosensors with superior analytical performance and real-time measurement. The development and dissemination of biosensor applications for exosome detection will be very advantageous for individuals in regions where there is no access to diagnostic devices and resources. Considering the disadvantages of traditional methods, we can say that biosensor studies are much more advantageous because they are cheaper, provide multi-analyte support, provide high sensitivity, and obtain fast and reliable results. In this study, recent developments in biosensor systems for the detection of exosomes secreted from different cancer cells are summarized. In addition, the use of cancer-secreted exosomes for point of care testing (POC) and the challenges in this area are presented and discussed.

Anahtar Kelimeler

Biosensor, Biomarker, Exosome, Diagnostic method

Kaynakça

  1. 1. Villarreal-Gómez, L. J., Soria-Mercado, I. E., Hernandez-Gómez, M., & Giraldi, R. G. (2015). Detection of molecular markers of cancer through the use of biosensors. Biol Med (Aligarh) S,2,
  2. 2. Jainish, P., & Prittesh, P. (2017). Biosensors and biomarkers: promising tools for cancer diagnosis. Int J Biosen Bioelectron, 3(4), 00072.
  3. 3. Makaju, S., Prasad, P. W. C., Alsadoon, A., Singh, A. K., & Elchouemi, A. (2018). Lung cancer detection using CT scan images. Procedia Computer Science, 125, 107-114.
  4. 4. Schoots, I. G. (2018). MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?. Translational andrology and urology, 7(1), 70.
  5. 5. Babayan, A., & Pantel, K. (2018). Advances in liquid biopsy approaches for early detection and monitoring of cancer. Genome medicine, 10(1), 1-3.
  6. 6. Zhu, C. Z., Ting, H. N., Ng, K. H., & Ong, T. A. (2019). A review on the accuracy of bladder cancer detection methods. Journal of Cancer, 10(17), 4038. 7. Weinstein, D., Leininger, J., Hamby, C., & Safai, B. (2014). Diagnostic and prognostic biomarkers in melanoma. The Journal of clinical and aesthetic dermatology, 7(6), 13.
  7. 8. Zhang, Y., Liu, Y., Liu, H., & Tang, W. H. (2019). Exosomes: biogenesis, biologic function and clinical potential. Cell & bioscience, 9(1), 19.
  8. 9. Lorencova, L., Bertok, T., Bertokova, A., Gajdosova, V., Hroncekova, S., Vikartovska, A., ...Tkac, J. (2020). Exosomes as a Source of Cancer Biomarkers: Advances in Electrochemical Biosensing of Exosomes. ChemElectroChem
  9. 10. Logozzi, M., Mizzoni, D., Angelini, D. F., Di Raimo, R., Falchi, M., Battistini, L., & Fais, S. (2018). Microenvironmental pH and exosome levels interplay in human cancer cell lines of different histotypes. Cancers, 10(10), 370.
  10. 11. McNicholas, K., & Michael, M. Z. (2017). Immuno-characterization of exosomes using nanoparticle tracking analysis. In Exosomes and Microvesicles (pp. 35-42). Humana Press, New York, NY.

Kaynak Göster

APA
Kelleci, K., & Özer, S. (2021). Biosensor Platforms for Cancer Derived Exosomes Detection. Yeni Yüzyıl Journal of Medical Sciences, 2(3), 22-31. https://izlik.org/JA58DS45GB
AMA
1.Kelleci K, Özer S. Biosensor Platforms for Cancer Derived Exosomes Detection. JMS. 2021;2(3):22-31. https://izlik.org/JA58DS45GB
Chicago
Kelleci, Kübra, ve Sevil Özer. 2021. “Biosensor Platforms for Cancer Derived Exosomes Detection”. Yeni Yüzyıl Journal of Medical Sciences 2 (3): 22-31. https://izlik.org/JA58DS45GB.
EndNote
Kelleci K, Özer S (01 Temmuz 2021) Biosensor Platforms for Cancer Derived Exosomes Detection. Yeni Yüzyıl Journal of Medical Sciences 2 3 22–31.
IEEE
[1]K. Kelleci ve S. Özer, “Biosensor Platforms for Cancer Derived Exosomes Detection”, JMS, c. 2, sy 3, ss. 22–31, Tem. 2021, [çevrimiçi]. Erişim adresi: https://izlik.org/JA58DS45GB
ISNAD
Kelleci, Kübra - Özer, Sevil. “Biosensor Platforms for Cancer Derived Exosomes Detection”. Yeni Yüzyıl Journal of Medical Sciences 2/3 (01 Temmuz 2021): 22-31. https://izlik.org/JA58DS45GB.
JAMA
1.Kelleci K, Özer S. Biosensor Platforms for Cancer Derived Exosomes Detection. JMS. 2021;2:22–31.
MLA
Kelleci, Kübra, ve Sevil Özer. “Biosensor Platforms for Cancer Derived Exosomes Detection”. Yeni Yüzyıl Journal of Medical Sciences, c. 2, sy 3, Temmuz 2021, ss. 22-31, https://izlik.org/JA58DS45GB.
Vancouver
1.Kübra Kelleci, Sevil Özer. Biosensor Platforms for Cancer Derived Exosomes Detection. JMS [Internet]. 01 Temmuz 2021;2(3):22-31. Erişim adresi: https://izlik.org/JA58DS45GB